Apr 16, 2020

Starpharma Reports Positive Results From SARS-CoV-2 Antiviral Testing Of SPL7013

Starpharma Reports Positive Results From SARS-CoV-2 Antiviral Testing Of SPL7013

NASDAQ covered the news that Starpharma’s VivaGel® active, astodrimer sodium (SPL7013), showed significant antiviral activity against the coronavirus that causes COVID-19. The piece noted the testing was conducted by an external laboratory, 360Biolabs.

To read the full article, click here.

 This contains certain forward-looking statements.